Core Insights - The company has made significant progress in expanding its MNC customer base, with revenue from MNCs reaching 514 million yuan in the first three quarters, representing a 68% year-on-year increase and accounting for 36% of total revenue [1] Group 1: Revenue Growth - Revenue from MNC customers reached 514 million yuan, a 68% increase year-on-year [1] - MNC revenue now constitutes 36% of the company's total revenue [1] Group 2: Factors Contributing to Growth - Global team development includes a 5-member business development team in Europe, with simultaneous expansion in North America and Japan, enhancing the "iron triangle" service model [1] - Upgrade in cooperation models from early-stage supply of molecular building blocks to late-stage clinical and commercialization projects, increasing customer stickiness [1] - Technological empowerment through AI-assisted design and continuous flow processes, effectively shortening R&D cycles and reinforcing differentiation with unique green chemistry technology [1] - Brand building efforts, including the successful hosting of the second Green Chemistry Forum, enhancing the company's image in sustainable development and chemical technology innovation [1] Group 3: Capacity Expansion - The company’s new 503 workshop, which started operations in February, adds a capacity of 190 million [1] - The company is currently in the capacity ramp-up phase, with expectations to reach utilization rates comparable to existing mature workshops by 2026 [1] - The application of advanced processes like continuous flow technology is expected to further enhance the efficiency of existing capacity [1]
药石科技:公司在MNC客户拓展方面取得显著进展